Acceleron Pharma (XLRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | XLRN | TECH | QGEN | ||
| Company | Acceleron Pharma | Bio-Techne Corp | Qiagen N.V. | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | ||
| Open | 179.85 | 71.48 | 40.98 | ||
| High | 179.85 | 72.63 | 41.23 | ||
| Low | 177.06 | 70.62 | 40.77 | ||
| Last | 178.75 | 71.44 | 41.10 | ||
| Change | -0.93 | -0.01 | +0.52 | ||
| % Change | -0.52% | -0.01% | +1.28% | ||
| Volume | 7,884,200 | 564,500 | 804,000 | ||
| 20-Day Average Volume | 1,302,050 | 1,088,080 | 1,004,780 | ||
| Previous Close | 179.68 | 71.45 | 40.58 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 174.46 | 74.35 | 42.42 | ||
| 20-Day Raw Stochastic | 84.01% | 8.81% | 19.28% | ||
| 20-Day Relative Strength | 70.12% | 39.31% | 42.88% | ||
| Weighted Alpha | +57.78 | -9.63 | -7.77 | ||
| Today's Opinion | 100% Buy | 8% Buy | 24% Sell | ||
| Previous Opinion | 100% Buy | 8% Buy | 24% Sell | ||
| Last Month's Opinion | 88% Buy | 88% Buy | 48% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.26% since 11/12/21 | -0.53% since 06/27/24 | unch since 06/27/24 | ||
| Low | 173.17 on 11/16/21 | 70.62 on 07/05/24 | 40.14 on 07/01/24 | ||
| High | 179.94 on 11/17/21 | 73.37 on 07/01/24 | 41.57 on 06/28/24 | ||
| 1-Month | |||||
| %Chg | +2.88% since 10/19/21 | -9.87% since 06/05/24 | -7.91% since 06/05/24 | ||
| Low | 172.25 on 10/20/21 | 70.62 on 07/05/24 | 40.14 on 07/01/24 | ||
| High | 179.94 on 11/17/21 | 79.93 on 06/06/24 | 45.12 on 06/10/24 | ||
| 3-Month | |||||
| %Chg | +48.97% since 08/19/21 | +6.64% since 04/05/24 | -0.17% since 04/05/24 | ||
| Low | 120.20 on 08/20/21 | 61.16 on 04/18/24 | 39.03 on 04/18/24 | ||
| High | 189.99 on 09/29/21 | 85.57 on 05/15/24 | 46.01 on 05/16/24 | ||
| 6-Month | |||||
| %Chg | +44.53% since 05/19/21 | +0.49% since 01/05/24 | -6.80% since 01/05/24 | ||
| Low | 113.49 on 07/15/21 | 61.16 on 04/18/24 | 39.03 on 04/18/24 | ||
| High | 189.99 on 09/29/21 | 85.57 on 05/15/24 | 46.01 on 05/16/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 10,931,634 | 11,259,449 | 9,260,478 | ||
| Shares Outstanding, K | 61,156 | 157,585 | 228,203 | ||
| Annual Sales | 92,520,000 | 1,136,700,000 | 1,965,310,000 | ||
| Annual Net Income | -166,030,000 | 285,260,000 | 341,300,000 | ||
| Last Quarter Sales | 34,200,000 | 303,430,000 | 458,800,000 | ||
| Last Quarter Net Income | -70,470,000 | 49,060,000 | 80,670,000 | ||
| 60-Month Beta | 0.13 | 1.29 | 0.40 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.16 on 11/04/21 | 0.48 on 05/01/24 | 0.46 on 04/29/24 | ||
| Latest Earnings Date | 11/04/21 | 08/13/24 | 07/31/24 | ||
| Most Recent Dividend | N/A | 0.080 on 05/10/24 | 0.027 on 12/27/02 | ||
| Next Ex-Dividends Date | N/A | 05/10/24 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 42.40 | 19.84 | ||